JP2009502829A5 - - Google Patents

Download PDF

Info

Publication number
JP2009502829A5
JP2009502829A5 JP2008523188A JP2008523188A JP2009502829A5 JP 2009502829 A5 JP2009502829 A5 JP 2009502829A5 JP 2008523188 A JP2008523188 A JP 2008523188A JP 2008523188 A JP2008523188 A JP 2008523188A JP 2009502829 A5 JP2009502829 A5 JP 2009502829A5
Authority
JP
Japan
Prior art keywords
alkylene
alkyl
halogen
aryl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008523188A
Other languages
English (en)
Japanese (ja)
Other versions
JP5060478B2 (ja
JP2009502829A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/007139 external-priority patent/WO2007012421A1/en
Publication of JP2009502829A publication Critical patent/JP2009502829A/ja
Publication of JP2009502829A5 publication Critical patent/JP2009502829A5/ja
Application granted granted Critical
Publication of JP5060478B2 publication Critical patent/JP5060478B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008523188A 2005-07-26 2006-07-20 Rho−キナーゼ阻害剤としてのピペリジニル置換されたイソキノロン誘導体 Active JP5060478B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05016154 2005-07-26
EP05016154.6 2005-07-26
PCT/EP2006/007139 WO2007012421A1 (en) 2005-07-26 2006-07-20 Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2009502829A JP2009502829A (ja) 2009-01-29
JP2009502829A5 true JP2009502829A5 (OSRAM) 2009-09-03
JP5060478B2 JP5060478B2 (ja) 2012-10-31

Family

ID=34979095

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008523188A Active JP5060478B2 (ja) 2005-07-26 2006-07-20 Rho−キナーゼ阻害剤としてのピペリジニル置換されたイソキノロン誘導体

Country Status (31)

Country Link
US (1) US8188117B2 (OSRAM)
EP (2) EP2385047B1 (OSRAM)
JP (1) JP5060478B2 (OSRAM)
KR (1) KR101373535B1 (OSRAM)
CN (1) CN101228149B (OSRAM)
AR (1) AR054868A1 (OSRAM)
AU (1) AU2006274245B2 (OSRAM)
BR (1) BRPI0613861B8 (OSRAM)
CA (1) CA2615577C (OSRAM)
CR (1) CR9603A (OSRAM)
DK (1) DK1910333T3 (OSRAM)
DO (1) DOP2006000178A (OSRAM)
EC (1) ECSP088135A (OSRAM)
ES (1) ES2423006T3 (OSRAM)
GT (1) GT200600328A (OSRAM)
IL (1) IL188702A (OSRAM)
MA (1) MA29636B1 (OSRAM)
MX (1) MX2008001053A (OSRAM)
MY (1) MY148479A (OSRAM)
NI (1) NI200800025A (OSRAM)
NO (1) NO341888B1 (OSRAM)
NZ (1) NZ565668A (OSRAM)
PE (1) PE20070217A1 (OSRAM)
PT (1) PT1910333E (OSRAM)
RU (1) RU2414467C2 (OSRAM)
TN (1) TNSN08039A1 (OSRAM)
TW (1) TWI383979B (OSRAM)
UA (1) UA93882C2 (OSRAM)
UY (1) UY29697A1 (OSRAM)
WO (1) WO2007012421A1 (OSRAM)
ZA (1) ZA200710951B (OSRAM)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006008945D1 (de) 2005-06-28 2009-10-15 Sanofi Aventis Isochinolinderivate als inhibitoren von rho-kinase
JP5049970B2 (ja) 2005-07-26 2012-10-17 サノフイ Rho−キナーゼ阻害剤としてのシクロヘキシルアミンイソキノロン誘導体
TW200738682A (en) * 2005-12-08 2007-10-16 Organon Nv Isoquinoline derivatives
ATE523493T1 (de) * 2006-09-11 2011-09-15 Organon Nv 2-(1-oxo-1h-isochinolin-2-yl) acetamid-derivate
ES2625266T3 (es) 2006-12-27 2017-07-19 Sanofi Derivados de isoquinolona sustituidos con cicloalquilamina
WO2008077554A1 (en) 2006-12-27 2008-07-03 Sanofi-Aventis Cycloalkylamine substituted isoquinoline derivatives
WO2008077550A1 (en) 2006-12-27 2008-07-03 Sanofi-Aventis Substituted isoquinoline and isoquinolinone derivatives as inhibitors of rho-kinase
ATE490243T1 (de) 2006-12-27 2010-12-15 Sanofi Aventis Cycloalkylaminsubstituierte isochinolin- und isochinolinonderivate
BRPI0720986A2 (pt) 2006-12-27 2014-03-11 Sanofi Aventis Derivados de isoquinolina e isoquinolinona substituídos
CA2673921C (en) 2006-12-27 2015-10-20 Sanofi-Aventis New substituted isoquinoline and isoquinolinone derivatives
US9623021B2 (en) * 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents
EA026578B1 (ru) * 2007-01-22 2017-04-28 ДЖиТиЭкс, ИНК. Вещества, связывающие ядерные рецепторы
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
JP2011507921A (ja) * 2007-12-26 2011-03-10 サノフィ−アベンティス 6−置換−1−(2h)−イソキノリノンの製造法
MX2010013975A (es) 2008-06-24 2011-01-14 Sanofi Aventis Isoquinolinas e isoquinolinonas sustituidas en calidad de inhibidores de la rho-quinasa.
DK2303845T3 (da) 2008-06-24 2013-12-16 Sanofi Sa Bi- og polycyklisk substitueret isoquinolin og bi- og polycykliske substituerede isoquinolinderivater som rho-kinasehæmmere
PL2313374T3 (pl) 2008-06-24 2014-03-31 Sanofi Sa 6-podstawione izochinoliny i izochinolinony
US9865233B2 (en) 2008-12-30 2018-01-09 Intel Corporation Hybrid graphics display power management
IN2012DN02968A (OSRAM) * 2009-10-13 2015-07-31 Msd Oss Bv
US9173395B2 (en) * 2011-07-04 2015-11-03 Bayer Intellectual Property Gmbh Use of substituted isoquinolinones, isoquinolindiones, isoquinolintriones and dihydroisoquinolinones or in each case salts thereof as active agents against abiotic stress in plants
KR102013566B1 (ko) * 2011-07-08 2019-08-23 사노피 6-(피페리딘-4-일옥시)-2h-이소퀴놀린-1-온 하이드로클로라이드의 결정성 용매화물
WO2013007502A1 (en) 2011-07-08 2013-01-17 Sanofi Substituted phenyl compounds
RU2014104357A (ru) * 2011-07-08 2015-08-20 Санофи Полиморфы гидрохлорида 6-(пиперидин-4-илокси)-2н-изохинолин-1-она
EP3141235A1 (en) 2012-12-06 2017-03-15 IP Gesellschaft für Management mbH N-(6-((2r,3s)-3,4-dihydroxybutan-2-yloxy)-2-(4-fluorobenzylthio)pyrimidin-4-yl)-3-methylazetidine-l -sulfonamide
CA3148196A1 (en) 2013-10-18 2015-04-23 Celgene Quanticel Research, Inc. Bromodomain inhibitors
CN105934246B (zh) 2013-11-18 2019-10-22 福马疗法公司 作为bet溴域抑制剂的四氢喹啉组成物
FR3017868A1 (fr) 2014-02-21 2015-08-28 Servier Lab Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BR112017013491A2 (pt) 2014-12-24 2018-01-09 Gilead Sciences, Inc. compostos de pirimidina fundida para o tratamento de hiv
TWI699355B (zh) 2014-12-24 2020-07-21 美商基利科學股份有限公司 喹唑啉化合物
WO2016105534A1 (en) 2014-12-24 2016-06-30 Gilead Sciences, Inc. Isoquinoline compounds for the treatment of hiv
AR104259A1 (es) 2015-04-15 2017-07-05 Celgene Quanticel Res Inc Inhibidores de bromodominio
WO2017003723A1 (en) 2015-07-01 2017-01-05 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
WO2017174879A1 (en) * 2016-04-06 2017-10-12 University Of Oulu Compounds for use in the treatment of cancer
EP3445750A4 (en) 2016-04-18 2019-11-27 Celgene Quanticel Research, Inc. THERAPEUTIC COMPOUNDS
US10150754B2 (en) 2016-04-19 2018-12-11 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
CN106632258B (zh) * 2016-12-15 2019-04-02 三峡大学 四氢异喹啉-2-基芳氧基苯氧基烷基酮化合物及其应用
WO2019023278A1 (en) 2017-07-25 2019-01-31 Crinetics Pharmaceuticals, Inc. MODULATORS OF SOMATOSTATIN AND USES THEREOF
US11738030B2 (en) 2021-10-30 2023-08-29 Aneuryst, Inc. Treatments for disturbed cerebral homeostasis
CA3260779A1 (en) * 2022-08-01 2024-02-08 Valo Health, Inc. PROCESS FOR PREPARATION OF 1-(2H)-ISOQUINOLINONES SUBSTITUTED AT POSITION 6 AND INTERMEDIATE COMPOUND

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2485537B2 (fr) 1977-04-13 1986-05-16 Anvar Dipyrido(4,3-b)(3,4-f)indoles, procede d'obtention, application therapeutique et compositions pharmaceutiques les contenant
WO1992002476A1 (en) 1990-07-31 1992-02-20 E.I. Du Pont De Nemours And Company Catalytic equilibration of selected halocarbons
US5480883A (en) 1991-05-10 1996-01-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
GB9516709D0 (en) 1995-08-15 1995-10-18 Zeneca Ltd Medicament
IL123293A (en) * 1995-09-07 2003-06-24 Hoffmann La Roche Piperidine derivatives, their preparation and pharmaceutical compositions containing them
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
IL128456A0 (en) 1996-08-12 2000-01-31 Yoshitomi Pharmaceutical Compositions containing a Rho kinase inhibitor
JPH1087629A (ja) 1996-09-18 1998-04-07 Fujisawa Pharmaceut Co Ltd 新規イソキノリン誘導体、およびその医薬用途
US6362191B1 (en) 1997-08-29 2002-03-26 Zeneca Ltd. Aminometyl oxooxazolidinyl benzene derivatives
TW575567B (en) 1998-10-23 2004-02-11 Akzo Nobel Nv Serine protease inhibitor
GB9912701D0 (en) 1999-06-01 1999-08-04 Smithkline Beecham Plc Novel compounds
US6541456B1 (en) 1999-12-01 2003-04-01 Isis Pharmaceuticals, Inc. Antimicrobial 2-deoxystreptamine compounds
AU779442B2 (en) 2000-01-20 2005-01-27 Eisai Co. Ltd. Novel piperidine compounds and drugs containing the same
US7217722B2 (en) * 2000-02-01 2007-05-15 Kirin Beer Kabushiki Kaisha Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
AU2001239947A1 (en) 2000-02-29 2001-09-12 Curis, Inc. Methods and compositions for regulating adipocytes
GB0004887D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
AR033517A1 (es) 2000-04-08 2003-12-26 Astrazeneca Ab Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos
GB0013060D0 (en) 2000-05-31 2000-07-19 Astrazeneca Ab Chemical compounds
WO2002034712A1 (en) 2000-10-27 2002-05-02 Takeda Chemical Industries, Ltd. Process for preparing substituted aromatic compounds and intermediates therefor
EP1351936A1 (en) 2001-01-15 2003-10-15 Glaxo Group Limited Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
SE0101038D0 (sv) 2001-03-23 2001-03-23 Astrazeneca Ab Novel compounds
JP2004534017A (ja) 2001-04-27 2004-11-11 バーテックス ファーマシューティカルズ インコーポレイテッド Baceのインヒビター
EP1403255A4 (en) * 2001-06-12 2005-04-06 Sumitomo Pharma RHO KINASE INHIBITORS
GB0117899D0 (en) 2001-07-23 2001-09-12 Astrazeneca Ab Chemical compounds
WO2003024450A1 (en) 2001-09-20 2003-03-27 Eisai Co., Ltd. Methods for treating prion diseases
SE0104340D0 (sv) 2001-12-20 2001-12-20 Astrazeneca Ab New compounds
EP1541559A4 (en) * 2002-07-22 2007-08-22 Asahi Kasei Pharma Corp 5-SUBSTITUTED ISOQUINOLINE DERIVATIVE
WO2004024717A1 (ja) 2002-09-12 2004-03-25 Kirin Beer Kabushiki Kaisha キナーゼ阻害活性を有するイソキノリン誘導体およびそれを含む医薬
US20040266755A1 (en) 2003-05-29 2004-12-30 Schering Aktiengesellschaft Prodrugs of 1-(1-hydroxy-5-isoquinolinesulfonyl) homopiperazine
EP1638939A2 (en) 2003-06-24 2006-03-29 Neurosearch A/S Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
CN1856476A (zh) 2003-09-23 2006-11-01 默克公司 异喹啉酮钾通道抑制剂
CN1856475A (zh) 2003-09-23 2006-11-01 默克公司 异喹啉钾通道抑制剂
US20050067037A1 (en) 2003-09-30 2005-03-31 Conocophillips Company Collapse resistant composite riser
US20070060595A1 (en) * 2003-10-10 2007-03-15 Toshio Yoshizawa Novel fused heterocyclic compound and use thereof
JP2007008816A (ja) * 2003-10-15 2007-01-18 Ube Ind Ltd 新規イソキノリン誘導体
EP1689719A1 (en) 2003-11-25 2006-08-16 Eli Lilly And Company 7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (proteinkinase b)
WO2005074535A2 (en) 2004-01-30 2005-08-18 Eisai Co., Ltd. Cholinesterase inhibitors for spinal cord disorders
WO2005087226A1 (en) 2004-03-05 2005-09-22 Eisai Co., Ltd. Cadasil treatment with cholinesterase inhibitors
SE0400850D0 (sv) 2004-03-30 2004-03-31 Astrazeneca Ab Novel Compounds
US7517991B2 (en) * 2004-10-12 2009-04-14 Bristol-Myers Squibb Company N-sulfonylpiperidine cannabinoid receptor 1 antagonists
JP5049970B2 (ja) 2005-07-26 2012-10-17 サノフイ Rho−キナーゼ阻害剤としてのシクロヘキシルアミンイソキノロン誘導体
TW200745101A (en) 2005-09-30 2007-12-16 Organon Nv 9-Azabicyclo[3.3.1]nonane derivatives
US7618985B2 (en) 2005-12-08 2009-11-17 N.V. Organon Isoquinoline derivatives
TW200738682A (en) * 2005-12-08 2007-10-16 Organon Nv Isoquinoline derivatives
US7893088B2 (en) 2006-08-18 2011-02-22 N.V. Organon 6-substituted isoquinoline derivatives
CA2673921C (en) 2006-12-27 2015-10-20 Sanofi-Aventis New substituted isoquinoline and isoquinolinone derivatives
ATE490243T1 (de) 2006-12-27 2010-12-15 Sanofi Aventis Cycloalkylaminsubstituierte isochinolin- und isochinolinonderivate

Similar Documents

Publication Publication Date Title
JP2009502829A5 (OSRAM)
JP2009502830A5 (OSRAM)
RU2008106950A (ru) Пиперидинилзамещенные производные изохинолона как ингибиторы rho-киназы
RU2008106926A (ru) Производные циклогексиламинизохинолона в качестве ингибиторов rho-киназы
RU2009128645A (ru) Замещенные изохинолиновые и изохинолиноновые производные в качестве ингибиторов rho-киназы
RU2008102968A (ru) Производные изохинолина в качестве ингибиторов rho-киназы
RU2013104459A (ru) Карбоксамидные соединения и их применение в качестве ингибиторов кальпаинов
JP2010511626A5 (OSRAM)
JP2010501584A5 (OSRAM)
RU2009128690A (ru) Новые замещенные производные изохинолина и изохинолинона
JP2008510691A5 (OSRAM)
ES2567630T3 (es) Derivados de tetrahidroindol como inhibidores de la NADPH oxidasa
JP2007502804A5 (OSRAM)
JP2019518766A5 (OSRAM)
CO6150132A2 (es) 4-[4-({[4--cloro-3-(trifluorometil)fenil]carbamoil}amino)-3-fluorofenoxil]-n-metilpiridina-2-carboxamida monohidrato
WO2006023460A3 (en) COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
JP2005505506A5 (OSRAM)
JP2006151984A5 (OSRAM)
RU2016144329A (ru) Агонисты рецептора апелина (apj) и его применение
RU2012132429A (ru) Бета-карболины для лечения нарушения слуха и головокружения
JP2008526999A5 (OSRAM)
JP2008510828A5 (OSRAM)
JP2005516967A5 (OSRAM)
JP2012526082A5 (OSRAM)
JP2012530137A5 (OSRAM)